Brian M Culley
CIK 1310683 · President and CEO · last filed 2026-03-12
Brian M Culley is a President and CEO who has filed 55 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing shows the insider bought $24.4K of LCTX on Mar 12, 2026. Across all open-market trades the lifetime net is −$1.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $324.5K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$324.5K
4
55
-$1.19M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LCTX | President and CEO | 255,516 | $1.27 | $324.5K | -$1.21M | 31 | 2026-03-12 |
| Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted | President and CEO | — | — | — | $0 | 1 | 2018-09-19 |
| MSTX | CEO and Director | — | $16.18 | — | $0 | 6 | 2017-01-23 |
| Savara Inc (ANX) Delisted | CEO and Director | 34,500 | — | — | $17.5K | 13 | 2013-01-03 |
Recent Filings
55 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-12 | LCTX | Buy (P) | +15,000 | $24.4K | EDGAR |
| 2026-03-06 | LCTX | Grant (A) | — | $0 | EDGAR |
| 2026-02-13 | LCTX | Mixed | +18,381 | -$23.2K | EDGAR |
| 2025-12-19 | LCTX | Mixed | +8,591 | -$561 | EDGAR |
| 2025-03-12 | LCTX | Grant (A) | — | $0 | EDGAR |
| 2025-02-12 | LCTX | Mixed | +18,702 | -$8.2K | EDGAR |
| 2024-11-22 | LCTX | Buy (P) | +40,000 | $24.0K | EDGAR |
| 2024-05-28 | LCTX | Buy (P) | +10,000 | $10.5K | EDGAR |
| 2024-03-08 | LCTX | Grant (A) | — | $0 | EDGAR |
| 2024-02-12 | LCTX | Mixed | +18,443 | -$13.8K | EDGAR |